Literature DB >> 20568812

Quantitative mass spectrometry defines an oxidative hotspot in hemoglobin that is specifically protected by haptoglobin.

Tatiana Pimenova1, Claudia P Pereira, Peter Gehrig, Paul W Buehler, Dominik J Schaer, Renato Zenobi.   

Abstract

The reaction of hemoglobin (Hb) with hydrogen peroxide (H(2)O(2)) results in free radicals generated at the heme iron, followed by radical transfer to the porphyrin/globin. In the present work, we employed isobaric tagging for relative and absolute quantification (iTRAQ) and a LC-MALDI-MS/MS-based proteomic approach to identify the extent of oxidative changes within tetrameric Hb and dimeric Hb-haptoglobin (Hb-Hp) complexes. Extensive oxidative modifications were found to be restricted to peptides containing alphaTyr42, betaTyr145, and betaCys93. The protein region composed of these peptides appears to define an area of oxidative activity within the Hb tetramer that extends across the critical alpha1beta2/alpha2beta1 interface. Extensive oxidative modifications occurring at betaCys93 indicate that this surface amino acid is an important end point for free radical induced protein oxidation within Hb. Conversely when Hp 1-1 or 2-2 was complexed with dissociable Hb, oxidative changes in Hp complexed dimeric Hb were prevented. This protection was not observed in a stabilized tetrameric Hb, which displays a weak binding affinity for Hp. Therefore, dimerization of Hb and Hp binding may interfere with free radical translocation and play an important role in the overall antioxidant mechanism of Hp. Interestingly, the prevention of peroxide induced Hb amino acid oxidation in purified Hb-Hp1-1 and Hb-Hp2-2 was found to be equal, indicating a phenotype independent specificity in the process of oxidative protection. Taken together, these data suggest differences in oxidative modifications resulting from peroxide induced heme emanated free radical distribution in tetrameric compared to Hp1-1/Hp2-2 stabilized dimeric Hb.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20568812     DOI: 10.1021/pr100252e

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  37 in total

1.  Structure of the haptoglobin-haemoglobin complex.

Authors:  Christian Brix Folsted Andersen; Morten Torvund-Jensen; Marianne Jensby Nielsen; Cristiano Luis Pinto de Oliveira; Hans-Petter Hersleth; Niels Højmark Andersen; Jan Skov Pedersen; Gregers Rom Andersen; Søren Kragh Moestrup
Journal:  Nature       Date:  2012-08-26       Impact factor: 49.962

Review 2.  Cell-free hemoglobin and its scavenger proteins: new disease models leading the way to targeted therapies.

Authors:  Dominik J Schaer; Paul W Buehler
Journal:  Cold Spring Harb Perspect Med       Date:  2013-06-01       Impact factor: 6.915

3.  Sickle Cell Hemoglobin in the Ferryl State Promotes βCys-93 Oxidation and Mitochondrial Dysfunction in Epithelial Lung Cells (E10).

Authors:  Tigist Kassa; Sirsendu Jana; Michael Brad Strader; Fantao Meng; Yiping Jia; Michael T Wilson; Abdu I Alayash
Journal:  J Biol Chem       Date:  2015-09-22       Impact factor: 5.157

4.  Haptoglobin binding stabilizes hemoglobin ferryl iron and the globin radical on tyrosine β145.

Authors:  Chris E Cooper; Dominik J Schaer; Paul W Buehler; Michael T Wilson; Brandon J Reeder; Gary Silkstone; Dimitri A Svistunenko; Leif Bulow; Abdu I Alayash
Journal:  Antioxid Redox Signal       Date:  2012-08-06       Impact factor: 8.401

5.  Effect of single amino acid substitution on oxidative modifications of the Parkinson's disease-related protein, DJ-1.

Authors:  Ashraf G Madian; Jagadish Hindupur; John D Hulleman; Naomi Diaz-Maldonado; Vartika R Mishra; Emmanuel Guigard; Cyril M Kay; Jean-Christophe Rochet; Fred E Regnier
Journal:  Mol Cell Proteomics       Date:  2011-11-21       Impact factor: 5.911

6.  Human Hp1-1 and Hp2-2 phenotype-specific haptoglobin therapeutics are both effective in vitro and in guinea pigs to attenuate hemoglobin toxicity.

Authors:  Miriam Lipiski; Jeremy W Deuel; Jin Hyen Baek; Wolfgang R Engelsberger; Paul W Buehler; Dominik J Schaer
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

Review 7.  Exploring Oxidative Reactions in Hemoglobin Variants Using Mass Spectrometry: Lessons for Engineering Oxidatively Stable Oxygen Therapeutics.

Authors:  Michael Brad Strader; Abdu I Alayash
Journal:  Antioxid Redox Signal       Date:  2016-10-20       Impact factor: 8.401

8.  Antioxidant functions for the hemoglobin β93 cysteine residue in erythrocytes and in the vascular compartment in vivo.

Authors:  Dario A Vitturi; Chiao-Wang Sun; Victoria M Harper; Bessy Thrash-Williams; Nadiezhda Cantu-Medellin; Balu K Chacko; Ning Peng; Yanying Dai; J Michael Wyss; Tim Townes; Rakesh P Patel
Journal:  Free Radic Biol Med       Date:  2012-11-16       Impact factor: 7.376

9.  Proteome-wide detection and quantitative analysis of irreversible cysteine oxidation using long column UPLC-pSRM.

Authors:  Chia-Fang Lee; Tanya T Paull; Maria D Person
Journal:  J Proteome Res       Date:  2013-09-06       Impact factor: 4.466

10.  Iron Homeostasis and Metabolism: Two Sides of a Coin.

Authors:  Vivek Venkataramani
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.